Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ryuji Hamamoto, Ken Masuda et al.|Cancer Science|2011Cited by 191
Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancerTae Young Ryu, Hyun‐Soo Cho|The ISME Journal|2022Cited by 130
Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerGouji Toyokawa, Ryuji Hamamoto, Ken Masuda et al.|Molecular Cancer|2011Cited by 113
Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase BHyun‐Soo Cho, Ryuji Hamamoto, Ken Masuda et al.|Nature Communications|2012Cited by 113
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt PathwayGouji Toyokawa, Ryuji Hamamoto, Hyun‐Soo Cho et al.|Neoplasia|2011Cited by 99